Mays Cancer Center studies help spur leukemia drug’s approval
March 1, 2022
The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Tuesday, March 1, 2022) — Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib […]
